Respiratory Syncytial Virus (RSV) Vaccine - Recombinant
Why is it prescribed?
Adults 60 years of age and older: prevention of lower respiratory tract disease (LRTD) caused by RSV.
Pregnant individuals from 32 through 36 weeks’ gestational age: prevention of LRTD and severe LRTD caused by RSV in infants from birth through 6 months of age.
This resource will only discuss the use in adults 60 years of age and older.
Products that have this ingredient include •Abrysvo™ •
See other drugs used in the treatment of •Respiratory Syncytial Virus (RSV) •
The most common side effects are
- pain, redness, swelling, discomfort at the injection site.
- fatigue
- headache
- muscle aches
Seek medical help immediately if you experience an allergic reaction: swelling of the face, lips, tongue or throat, hives, difficulty breathing or swallowing
The RSV vaccine helps the body make antibodies and white blood cells that fight against the RSV-A or RSV-B subtypes in adults aged 60 years and older. The RSV virus can can cause severe influenza-like illness and lower respiratory tract illness in some people.
Do not get this vaccine if you have:
- had previous life-threatening allergic reaction to any component of the vaccine (check with your health care provider for vaccine ingredients)
- a serious illness with a high temperature. A minor infection such as a cold, including mild fever, should not require you to postpone the vaccination.